S19 Novel antitumor substances from microbial origin
Tuesday, January 13, 2015: 10:40 AM
California Ballroom AB
Takashi Sakai, Natural Product Lead Discovery Group, Eisai Co., Ltd., TSUKUBA-SHI
ID# 28668 Eisai_Takashi Sakai_revised.pdf
In our screening of microorganisms, new macrolide, which we termed pladienolide, was found out, leading to developing E7107 possessing unique MOA as antitumor drug candidate. I would like to show you our Natural Product research program.
Back to Session: Natural Products from Bench to Clinic
<< Previous Paper | Next Paper >>